Fundz

Nanopath

Cambridge, United States · Biotechnology, Health Care

Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

Key facts

Headquarters
Cambridge, United States
Employees
25
Industries
Biotechnology, Health Care
Status
Private
Website
nanopath.com
LinkedIn
Company page

Recent activity at Nanopath

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Nanopath funding history

DateRoundAmount
Nov 2026Series B$25.0M
Jan 2025Venture$5.3M
May 2024Seed$4.0M
Aug 2022Series A$10.0M

Leadership

  • Amogha Tadimety, Co-Founder & CEO
  • Matt Cote, Vice President of Engineering
  • Matthew Black, Chief Scientific Officer
  • Edward Evantash, Chief Medical Officer
  • Alison Burklund, Chief Executive Officer

Verified email and direct lines for Nanopath’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Nanopath files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Nanopath in the news

Companies similar to Nanopath

About Nanopath: questions and answers

What does Nanopath do?

Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

Where is Nanopath headquartered?

Nanopath is headquartered in Cambridge, United States.

How many employees does Nanopath have?

Nanopath has about 25 employees.

Has Nanopath raised funding?

Yes. Fundz has recorded 4 funding events for Nanopath. The most recent, Series B of $25.0M, was in Nov 2026.

Who leads Nanopath?

Amogha Tadimety is a Co-Founder & CEO at Nanopath.

What is the latest news on Nanopath?

On Nov 10, 2026, Nanopath announces the close of a $25 million Series B financing to advance molecular testing for women's health, co-led by Norwest and SV Health Investors.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Nanopath across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.